David Rosenbaum
Corporate Officer/Principal presso ARDELYX, INC.
Patrimonio netto: 4 M $ in data 31/05/2024
Profilo
David P.
Rosenbaum's current job is Chief Development Officer at Ardelyx, Inc. He started this position in 2015.
Dr. Rosenbaum's former jobs include being a Study Director at Arthur D.
Little, Inc. from 1990 to 1993, Vice President-Preclinical Research & Development at GelTex Pharmaceuticals, Inc. from 1994 to 1999, and Vice President-Product Development at Trine Pharmaceuticals, Inc. from 2003 to 2008.
Dr. Rosenbaum's education includes an undergraduate degree from the University of Pennsylvania in 1982, a graduate degree from Albany Medical College, and a doctorate degree from Boston University School of Medicine in 1989.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ARDELYX, INC.
0.26% | 03/06/2024 | 612 573 ( 0.26% ) | 4 M $ | 31/05/2024 |
Posizioni attive di David Rosenbaum
| Società | Posizione | Inizio |
|---|---|---|
| ARDELYX, INC. | Corporate Officer/Principal | 01/01/2010 |
Precedenti posizioni note di David Rosenbaum
| Società | Posizione | Fine |
|---|---|---|
Trine Pharmaceuticals, Inc.
 Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Trine Pharmaceuticals, Inc. develops and markets pharmaceutical products. It develops drugs which are used in the areas of renal, gastrointestinal and metabolic diseases. The company is headquartered in Waltham, MA. | Corporate Officer/Principal | 19/09/2008 |
GelTex Pharmaceuticals, Inc.
 GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA. | Corporate Officer/Principal | 01/01/1999 |
Arthur D. Little, Inc.
 Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/01/1993 |
Formazione di David Rosenbaum
| University of Pennsylvania | Undergraduate Degree |
| Albany Medical College | Graduate Degree |
| Boston University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ARDELYX, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Trine Pharmaceuticals, Inc.
Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Trine Pharmaceuticals, Inc. develops and markets pharmaceutical products. It develops drugs which are used in the areas of renal, gastrointestinal and metabolic diseases. The company is headquartered in Waltham, MA. | Health Technology |
Arthur D. Little, Inc.
Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA. | Commercial Services |
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- David Rosenbaum
